Loading…

Role of dyslipidemia in ischemic stroke patients treated in the telestroke network

The relationship between the telestroke technology and clinical risk factors in a dysplipidemic ischemic stroke population and neurologic outcomes is not fully understood. This issue was investigated in this study. We analyzed retrospective data collected from a regional stroke registry to identify...

Full description

Saved in:
Bibliographic Details
Published in:Advances in medical sciences 2021-09, Vol.66 (2), p.254-261
Main Authors: Brechtel, Leanne, Poupore, Nicolas, Monroe, Margaret, Knisely, Krista, Sanders, Carolyn, Edrissi, Camron, Rathfoot, Chase, Nathaniel, Thomas I.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c359t-d6683bec6eee7068875911d3076c16e24293f6e1963b10190f8bee3f5343847a3
cites cdi_FETCH-LOGICAL-c359t-d6683bec6eee7068875911d3076c16e24293f6e1963b10190f8bee3f5343847a3
container_end_page 261
container_issue 2
container_start_page 254
container_title Advances in medical sciences
container_volume 66
creator Brechtel, Leanne
Poupore, Nicolas
Monroe, Margaret
Knisely, Krista
Sanders, Carolyn
Edrissi, Camron
Rathfoot, Chase
Nathaniel, Thomas I.
description The relationship between the telestroke technology and clinical risk factors in a dysplipidemic ischemic stroke population and neurologic outcomes is not fully understood. This issue was investigated in this study. We analyzed retrospective data collected from a regional stroke registry to identify demographic and clinical risk factors in patients with improving (NIHSS ​≤ ​7) or worsening (NIHSS ​> ​7) neurologic outcome in dyslipidemic ischemic stroke population. We used logistic multivariate models to identify independent predictors of improving or worsening outcome based on dyslipidemia disease status in ischemic stroke patients. In the adjusted analysis for dyslipidemic ischemic stroke population, cholesterol reducer use (odd ratio; [OR] ​= ​0.393, 95% confidence interval [CI], 0.176–0.879, P ​= ​0.023) and direct admission (OR ​= ​0.435, 95% CI, 0.199–0.953, P ​= ​0.037) were more likely to be associated with neurologic improvement and no clinical or demographic factors were associated with poor neurologic outcome in dyslipidemic ischemic stroke patients treated in the telestroke network. For the ischemic stroke population without dyslipidemia, increasing age (OR ​= ​1.070, 95% CI, 1.031–1.109, P ​
doi_str_mv 10.1016/j.advms.2021.04.003
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2522187917</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1896112621000237</els_id><sourcerecordid>2522187917</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-d6683bec6eee7068875911d3076c16e24293f6e1963b10190f8bee3f5343847a3</originalsourceid><addsrcrecordid>eNp9kMlOwzAQhi0EoqXwBEgoRy4JYztxkgMHhNikSkgVnK3EnqhusxTbLerb4y5w5DRz-P5ZPkKuKSQUqLhbJJXedC5hwGgCaQLAT8iYFmURpwDsdN-LmFImRuTCuQWAYALgnIw4L1PImBiT2WxoMRqaSG9da1ZGY2eqyPSRcWoeehU5b4clRqvKG-y9i7zFyqPeMX6OkccWj0iP_nuwy0ty1lStw6tjnZDP56ePx9d4-v7y9vgwjRXPSh9rIQpeoxKImIMoijwrKdUccqGoQJaykjcCaSl4Hf4toSlqRN5kPOVFmld8Qm4Pc1d2-FqHI2QXjsa2rXoc1k6yjDFa5CXNA8oPqLKDcxYbubKmq-xWUpA7mXIh9zLlTqaEVAaZIXVzXLCuO9R_mV97Abg_ABje3Bi00qkgSaE2FpWXejD_LvgBa1-GSw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2522187917</pqid></control><display><type>article</type><title>Role of dyslipidemia in ischemic stroke patients treated in the telestroke network</title><source>Elsevier</source><creator>Brechtel, Leanne ; Poupore, Nicolas ; Monroe, Margaret ; Knisely, Krista ; Sanders, Carolyn ; Edrissi, Camron ; Rathfoot, Chase ; Nathaniel, Thomas I.</creator><creatorcontrib>Brechtel, Leanne ; Poupore, Nicolas ; Monroe, Margaret ; Knisely, Krista ; Sanders, Carolyn ; Edrissi, Camron ; Rathfoot, Chase ; Nathaniel, Thomas I.</creatorcontrib><description>The relationship between the telestroke technology and clinical risk factors in a dysplipidemic ischemic stroke population and neurologic outcomes is not fully understood. This issue was investigated in this study. We analyzed retrospective data collected from a regional stroke registry to identify demographic and clinical risk factors in patients with improving (NIHSS ​≤ ​7) or worsening (NIHSS ​&gt; ​7) neurologic outcome in dyslipidemic ischemic stroke population. We used logistic multivariate models to identify independent predictors of improving or worsening outcome based on dyslipidemia disease status in ischemic stroke patients. In the adjusted analysis for dyslipidemic ischemic stroke population, cholesterol reducer use (odd ratio; [OR] ​= ​0.393, 95% confidence interval [CI], 0.176–0.879, P ​= ​0.023) and direct admission (OR ​= ​0.435, 95% CI, 0.199–0.953, P ​= ​0.037) were more likely to be associated with neurologic improvement and no clinical or demographic factors were associated with poor neurologic outcome in dyslipidemic ischemic stroke patients treated in the telestroke network. For the ischemic stroke population without dyslipidemia, increasing age (OR ​= ​1.070, 95% CI, 1.031–1.109, P ​&lt; ​0.001), coronary artery disease (OR ​= ​3.633, 95% CI, 1.307–10.099, P ​= ​0.013), history of drug or alcohol abuse (OR ​= ​6.548, 95% CI, 1.106–38.777, P ​= ​0.038), and improvement in ambulatory outcome (OR ​= ​2.880, 95% CI, 1.183–7.010, P ​= ​0.020) were associated with worsening neurological functions, while being Caucasian (OR ​= ​0.294, 95% CI, 0.098–0.882, P ​= ​0.029) was associated with improving neurologic functions. Demographic and clinical risk factors among the dysplipidemic ischemic stroke population in the telestroke network were not associated with worsening neurologic functions.</description><identifier>ISSN: 1896-1126</identifier><identifier>EISSN: 1898-4002</identifier><identifier>DOI: 10.1016/j.advms.2021.04.003</identifier><identifier>PMID: 33940526</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Brain Ischemia - complications ; Dyslipidemia ; Dyslipidemias - complications ; Dyslipidemias - epidemiology ; Humans ; Ischemic Stroke ; Neurologic outcome ; NIHSS score ; Retrospective Studies ; Risk Factors ; Stroke ; Stroke - complications ; Telestroke ; Time Factors ; Treatment Outcome</subject><ispartof>Advances in medical sciences, 2021-09, Vol.66 (2), p.254-261</ispartof><rights>2021 Medical University of Bialystok</rights><rights>Copyright © 2021 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-d6683bec6eee7068875911d3076c16e24293f6e1963b10190f8bee3f5343847a3</citedby><cites>FETCH-LOGICAL-c359t-d6683bec6eee7068875911d3076c16e24293f6e1963b10190f8bee3f5343847a3</cites><orcidid>0000-0001-7488-859X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33940526$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brechtel, Leanne</creatorcontrib><creatorcontrib>Poupore, Nicolas</creatorcontrib><creatorcontrib>Monroe, Margaret</creatorcontrib><creatorcontrib>Knisely, Krista</creatorcontrib><creatorcontrib>Sanders, Carolyn</creatorcontrib><creatorcontrib>Edrissi, Camron</creatorcontrib><creatorcontrib>Rathfoot, Chase</creatorcontrib><creatorcontrib>Nathaniel, Thomas I.</creatorcontrib><title>Role of dyslipidemia in ischemic stroke patients treated in the telestroke network</title><title>Advances in medical sciences</title><addtitle>Adv Med Sci</addtitle><description>The relationship between the telestroke technology and clinical risk factors in a dysplipidemic ischemic stroke population and neurologic outcomes is not fully understood. This issue was investigated in this study. We analyzed retrospective data collected from a regional stroke registry to identify demographic and clinical risk factors in patients with improving (NIHSS ​≤ ​7) or worsening (NIHSS ​&gt; ​7) neurologic outcome in dyslipidemic ischemic stroke population. We used logistic multivariate models to identify independent predictors of improving or worsening outcome based on dyslipidemia disease status in ischemic stroke patients. In the adjusted analysis for dyslipidemic ischemic stroke population, cholesterol reducer use (odd ratio; [OR] ​= ​0.393, 95% confidence interval [CI], 0.176–0.879, P ​= ​0.023) and direct admission (OR ​= ​0.435, 95% CI, 0.199–0.953, P ​= ​0.037) were more likely to be associated with neurologic improvement and no clinical or demographic factors were associated with poor neurologic outcome in dyslipidemic ischemic stroke patients treated in the telestroke network. For the ischemic stroke population without dyslipidemia, increasing age (OR ​= ​1.070, 95% CI, 1.031–1.109, P ​&lt; ​0.001), coronary artery disease (OR ​= ​3.633, 95% CI, 1.307–10.099, P ​= ​0.013), history of drug or alcohol abuse (OR ​= ​6.548, 95% CI, 1.106–38.777, P ​= ​0.038), and improvement in ambulatory outcome (OR ​= ​2.880, 95% CI, 1.183–7.010, P ​= ​0.020) were associated with worsening neurological functions, while being Caucasian (OR ​= ​0.294, 95% CI, 0.098–0.882, P ​= ​0.029) was associated with improving neurologic functions. Demographic and clinical risk factors among the dysplipidemic ischemic stroke population in the telestroke network were not associated with worsening neurologic functions.</description><subject>Brain Ischemia - complications</subject><subject>Dyslipidemia</subject><subject>Dyslipidemias - complications</subject><subject>Dyslipidemias - epidemiology</subject><subject>Humans</subject><subject>Ischemic Stroke</subject><subject>Neurologic outcome</subject><subject>NIHSS score</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Stroke</subject><subject>Stroke - complications</subject><subject>Telestroke</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>1896-1126</issn><issn>1898-4002</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kMlOwzAQhi0EoqXwBEgoRy4JYztxkgMHhNikSkgVnK3EnqhusxTbLerb4y5w5DRz-P5ZPkKuKSQUqLhbJJXedC5hwGgCaQLAT8iYFmURpwDsdN-LmFImRuTCuQWAYALgnIw4L1PImBiT2WxoMRqaSG9da1ZGY2eqyPSRcWoeehU5b4clRqvKG-y9i7zFyqPeMX6OkccWj0iP_nuwy0ty1lStw6tjnZDP56ePx9d4-v7y9vgwjRXPSh9rIQpeoxKImIMoijwrKdUccqGoQJaykjcCaSl4Hf4toSlqRN5kPOVFmld8Qm4Pc1d2-FqHI2QXjsa2rXoc1k6yjDFa5CXNA8oPqLKDcxYbubKmq-xWUpA7mXIh9zLlTqaEVAaZIXVzXLCuO9R_mV97Abg_ABje3Bi00qkgSaE2FpWXejD_LvgBa1-GSw</recordid><startdate>202109</startdate><enddate>202109</enddate><creator>Brechtel, Leanne</creator><creator>Poupore, Nicolas</creator><creator>Monroe, Margaret</creator><creator>Knisely, Krista</creator><creator>Sanders, Carolyn</creator><creator>Edrissi, Camron</creator><creator>Rathfoot, Chase</creator><creator>Nathaniel, Thomas I.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7488-859X</orcidid></search><sort><creationdate>202109</creationdate><title>Role of dyslipidemia in ischemic stroke patients treated in the telestroke network</title><author>Brechtel, Leanne ; Poupore, Nicolas ; Monroe, Margaret ; Knisely, Krista ; Sanders, Carolyn ; Edrissi, Camron ; Rathfoot, Chase ; Nathaniel, Thomas I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-d6683bec6eee7068875911d3076c16e24293f6e1963b10190f8bee3f5343847a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Brain Ischemia - complications</topic><topic>Dyslipidemia</topic><topic>Dyslipidemias - complications</topic><topic>Dyslipidemias - epidemiology</topic><topic>Humans</topic><topic>Ischemic Stroke</topic><topic>Neurologic outcome</topic><topic>NIHSS score</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Stroke</topic><topic>Stroke - complications</topic><topic>Telestroke</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brechtel, Leanne</creatorcontrib><creatorcontrib>Poupore, Nicolas</creatorcontrib><creatorcontrib>Monroe, Margaret</creatorcontrib><creatorcontrib>Knisely, Krista</creatorcontrib><creatorcontrib>Sanders, Carolyn</creatorcontrib><creatorcontrib>Edrissi, Camron</creatorcontrib><creatorcontrib>Rathfoot, Chase</creatorcontrib><creatorcontrib>Nathaniel, Thomas I.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Advances in medical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brechtel, Leanne</au><au>Poupore, Nicolas</au><au>Monroe, Margaret</au><au>Knisely, Krista</au><au>Sanders, Carolyn</au><au>Edrissi, Camron</au><au>Rathfoot, Chase</au><au>Nathaniel, Thomas I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of dyslipidemia in ischemic stroke patients treated in the telestroke network</atitle><jtitle>Advances in medical sciences</jtitle><addtitle>Adv Med Sci</addtitle><date>2021-09</date><risdate>2021</risdate><volume>66</volume><issue>2</issue><spage>254</spage><epage>261</epage><pages>254-261</pages><issn>1896-1126</issn><eissn>1898-4002</eissn><abstract>The relationship between the telestroke technology and clinical risk factors in a dysplipidemic ischemic stroke population and neurologic outcomes is not fully understood. This issue was investigated in this study. We analyzed retrospective data collected from a regional stroke registry to identify demographic and clinical risk factors in patients with improving (NIHSS ​≤ ​7) or worsening (NIHSS ​&gt; ​7) neurologic outcome in dyslipidemic ischemic stroke population. We used logistic multivariate models to identify independent predictors of improving or worsening outcome based on dyslipidemia disease status in ischemic stroke patients. In the adjusted analysis for dyslipidemic ischemic stroke population, cholesterol reducer use (odd ratio; [OR] ​= ​0.393, 95% confidence interval [CI], 0.176–0.879, P ​= ​0.023) and direct admission (OR ​= ​0.435, 95% CI, 0.199–0.953, P ​= ​0.037) were more likely to be associated with neurologic improvement and no clinical or demographic factors were associated with poor neurologic outcome in dyslipidemic ischemic stroke patients treated in the telestroke network. For the ischemic stroke population without dyslipidemia, increasing age (OR ​= ​1.070, 95% CI, 1.031–1.109, P ​&lt; ​0.001), coronary artery disease (OR ​= ​3.633, 95% CI, 1.307–10.099, P ​= ​0.013), history of drug or alcohol abuse (OR ​= ​6.548, 95% CI, 1.106–38.777, P ​= ​0.038), and improvement in ambulatory outcome (OR ​= ​2.880, 95% CI, 1.183–7.010, P ​= ​0.020) were associated with worsening neurological functions, while being Caucasian (OR ​= ​0.294, 95% CI, 0.098–0.882, P ​= ​0.029) was associated with improving neurologic functions. Demographic and clinical risk factors among the dysplipidemic ischemic stroke population in the telestroke network were not associated with worsening neurologic functions.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>33940526</pmid><doi>10.1016/j.advms.2021.04.003</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-7488-859X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1896-1126
ispartof Advances in medical sciences, 2021-09, Vol.66 (2), p.254-261
issn 1896-1126
1898-4002
language eng
recordid cdi_proquest_miscellaneous_2522187917
source Elsevier
subjects Brain Ischemia - complications
Dyslipidemia
Dyslipidemias - complications
Dyslipidemias - epidemiology
Humans
Ischemic Stroke
Neurologic outcome
NIHSS score
Retrospective Studies
Risk Factors
Stroke
Stroke - complications
Telestroke
Time Factors
Treatment Outcome
title Role of dyslipidemia in ischemic stroke patients treated in the telestroke network
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T19%3A19%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20dyslipidemia%20in%20ischemic%20stroke%20patients%20treated%20in%20the%20telestroke%20network&rft.jtitle=Advances%20in%20medical%20sciences&rft.au=Brechtel,%20Leanne&rft.date=2021-09&rft.volume=66&rft.issue=2&rft.spage=254&rft.epage=261&rft.pages=254-261&rft.issn=1896-1126&rft.eissn=1898-4002&rft_id=info:doi/10.1016/j.advms.2021.04.003&rft_dat=%3Cproquest_cross%3E2522187917%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c359t-d6683bec6eee7068875911d3076c16e24293f6e1963b10190f8bee3f5343847a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2522187917&rft_id=info:pmid/33940526&rfr_iscdi=true